Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Dementia, Mild: full-pipeline trial registry

4 of 11 indexed Dementia, Mild trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 4 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Dementia, Mild: 11 US clinical trials tracked, 4 recruiting.

Dementia, Mild is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Texas at Austin, running 2 of these trials.

Enrollment posture brief

Registry condition dementia-mild

OPEN 4 | RECR 36% | LATE 1 | EARLY 1 | RANK #1577 | SPON 2

Nearest open-share peer: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (36% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Dementia, Mild (this)36%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Dementia, Mild

Dementia, Mild lists 4 open slots (36% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Dementia, Mild on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Dementia, Mild is recruiting below its size-band peers.

    4 of 11 indexed trials (36.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Dementia, Mild research.

    University of Texas at Austin accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Typical Dementia, Mild enrolment sits around 100 participants.

    Median target enrolment is 100 among the 11 trials that report a genuine target (sentinel values excluded). 5 of those (45.5%) plan for fewer than 100 participants.

  4. Dementia, Mild research is mostly interventional.

    10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31

Open and recent trials

11 total, page 1 of 1

RECRUITING NA 240 participants

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

University of Washington

NCT06817122

RECRUITING NA 200 participants

Paper-Based and Smartphone-Based Memory Supports

Baylor University

NCT06444841

RECRUITING NA 100 participants

Cognitive Screening Made Easy for PCPs - Administrative Supplement

University of Texas at Austin

NCT06928298

RECRUITING NA 60 participants

Pain With Dementia

Duke University

NCT06854718

ACTIVE NOT RECRUITING NA 500 participants

Cognitive Screening Made Easy for PCPs - R33 Phase

University of Texas at Austin

NCT06162026

ACTIVE NOT RECRUITING Phase 2 247 participants

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Actinogen Medical

NCT06125951

ACTIVE NOT RECRUITING NA 95 participants

The Brain Health Champion Study

Brigham and Women's Hospital

NCT03772977

ACTIVE NOT RECRUITING NA 60 participants

Multi-Center Study of Sensory Stimulation to Improve Brain Function

Cognito Therapeutics

NCT03556280

COMPLETED 219 participants

Family Caregiver Online Survey (Dementia and Swallowing Difficulties)

University of Oregon

NCT06471660

COMPLETED NA 74 participants

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

Johns Hopkins University

NCT05187117

COMPLETED Phase 3 73 participants

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

Alzheimer's Prevention and Reversal Project

NCT05894954

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Dementia, Mild records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

RACS app Behavioral
2 trials
Lifestyle including diet, exercise, stress management Behavioral
1 trials
Standard-of-Care Behavioral
1 trials
Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises Combination
1 trials
Precision Medicine Approach Dietary supplement
1 trials
CAPABLE Family - Randomized Control Trial Behavioral
1 trials
CAPABLE Family - Open Label Pilot Behavioral
1 trials
GammaSense Stimulation System (Sham Settings) Device
1 trials

US sites by state

Facility locations filed on Dementia, Mild trials. A trial with sites in several states counts in each.

Texas 4 trials
Florida 3 trials
Washington 2 trials
Oregon 2 trials
Ohio 2 trials
New Jersey 2 trials
Massachusetts 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Dementia, Mild page

11 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia, Mild condition card totals 11 registered trials; most-linked intervention RACS app; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.